MediciNova, Inc.
4350 La Jolla Village Drive, Suite 950
San Diego
California
92122
United States
Tel: 858-373-1500
Fax: 858-373-7000
Website: http://www.medicinova.com/
Email: info@medicinova.com
334 articles about MediciNova, Inc.
-
MediciNova, Inc. Appoints Mr. Tatsuo Izumi to Its Board of Directors
9/26/2011
-
MediciNova, Inc. Announces Management Appointments
9/2/2011
-
MediciNova, Inc. Reports Second Quarter 2011 Results
8/16/2011
-
MediciNova, Inc. to Collaborate on a Phase 2 Trial of Ibudilast (MN-166/AV411) in Medication Overuse Headache
8/11/2011
-
MediciNova, Inc. Announces Second Quarter 2011 Earnings Conference Call and Webcast
8/11/2011
-
MediciNova, Inc. and Zhejiang Medicine Company Group Finalize Agreement for Joint Venture in China
6/30/2011
-
MediciNova, Inc. Reports First Quarter 2011 Results
5/17/2011
-
MediciNova, Inc. Announces First Quarter 2011 Earnings Conference Call and Webcast
5/12/2011
-
Reminder: MediciNova, Inc. to Host Business Update Conference Call by Management on April 7, 2011
4/7/2011
-
MediciNova, Inc. to Host Business Update Conference Call by Management on April 7, 2011
4/6/2011
-
MediciNova, Inc. Reports Fourth Quarter and Full Year 2010 Results
4/1/2011
-
MediciNova, Inc. Prices $8.25 Million Public Offering of Common Stock and Warrants
3/24/2011
-
MediciNova, Inc. Receives a Notice of Allowance for a Method of Treating Drug Addiction or Dependence
3/10/2011
-
MediciNova, Inc. and Zhejiang Medicine to Set Up China JV for Asthma Drug
3/4/2011
-
MediciNova, Inc. Reports Third Quarter 2010 Results
11/16/2010
-
MediciNova, Inc.''s MN-166 Program Recognized as One of Windhover Information Inc.'s Top 10 Neuroscience Projects to Watch
10/20/2010
-
University of California, Los Angeles (UCLA) Initiates a NIDA-Supported Phase 1b Study With MediciNova, Inc.'s Ibudilast in Methamphetamine-Dependent Volunteers
9/27/2010
-
MediciNova, Inc. to Present at the Rodman & Renshaw Annual Global Investment Conference
9/2/2010
-
MediciNova, Inc. Announces Estimated Timing of Payments to Former Avigen, Inc. Stockholders
7/13/2010
-
Insight on MediciNova, Inc.'s MN-166 Mechanism of Action Reported in PNAS
7/8/2010